Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01183962 · ClinicalTrials.gov registry record · NA
Vitamin D and T-Regulatory Cells in Coronary Artery Disease
A NA study, sponsored by Creighton University.
- Terminated
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT01183962 is a NA study that was terminated before completion, run by Creighton University. The registered enrollment target is 50 participants.
The verdict
NCT01183962, a NA study, was terminated before completion, sponsored by Creighton University.
- TERMINATED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of Vitamin D supplementation on cardiovascular disease and certain cells (T-regulatory cells) in the body that play a role in plaque formation in arteries. This study will determine the levels of Vitamin D and T-regulatory cells in subjects with coronary artery disease and if Vitamin D supplementation will affect future events such as heart attach and stroke.
Interventions
- DIETARY_SUPPLEMENT Vitamin D
- OTHER No medication
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01183962
The ClinicalTrials.gov registry entry for NCT01183962 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin D is the first listed.
NCT01183962 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01183962 about?
NCT01183962 is a clinical study titled "Vitamin D and T-Regulatory Cells in Coronary Artery Disease". The purpose of this study is to evaluate the effect of Vitamin D supplementation on cardiovascular disease and certain cells (T-regulatory cells) in the body that play a role in plaque formation in arteries. This study will determine the levels of Vitamin D and T-regulatory cells in subjects with co...
What is the current status of trial NCT01183962?
This trial is currently terminated. It is a NA study. The enrollment target is 50 participants. The study started on 2010-02.
What interventions are being tested in trial NCT01183962?
The interventions under investigation include: Vitamin D (DIETARY_SUPPLEMENT), No medication (OTHER).
Who is sponsoring clinical trial NCT01183962?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.